SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹234 Cr | ₹204 Cr | ₹200 Cr | ₹16,826,961 Cr | ₹167 Cr |
What is the latest Total Expenditure of SYNCOM FORMULATIONS (INDIA) ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹234 Cr |
| Mar2024 | ₹204 Cr |
| Mar2023 | ₹200 Cr |
| Mar2022 | ₹16,826,961 Cr |
| Mar2017 | ₹167 Cr |
How is Total Expenditure of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹234 Cr | 14.38 | |
| Mar2024 | ₹204 Cr | 2.37 | |
| Mar2023 | ₹200 Cr | -100.00 | |
| Mar2022 | ₹16,826,961 Cr | 10,062,186.55 | |
| Mar2017 | ₹167 Cr | - | |
Compare Total Expenditure of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,239.9 Cr | 2.5% | -3.8% | -27.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 2.5% |
-3.8% |
-27.3% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses